[Review on the Combination Strategy of Anti-angiogenic Agents and Other Anti-tumor Agents in Advanced Non-small Cell Lung Cancer]. [PDF]
Xu Z, Li J.
europepmc +1 more source
[Research Progress of Anti-PD-1/PD-L1 Therapy for Non-small Cell Lung Cancer with EGFR Mutation]. [PDF]
Zhu Y, Dai Z.
europepmc +1 more source
[Success rate of one-stop procedure for atrial fibrillation ablation and its impact on cardiac function: a propensity-matched study]. [PDF]
Zhu S+6 more
europepmc +1 more source
[Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer]. [PDF]
Li H, Wang J.
europepmc +1 more source
[Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version)]. [PDF]
Zhou C+24 more
europepmc +1 more source
Complement cascade inhibition in geographic atrophy: a review. [PDF]
Desai D, Dugel PU.
europepmc +1 more source
[Research Progress of Anti-angiogenic Agents Combined with Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer]. [PDF]
Wang J, Peng W, Jiang M, Wu L.
europepmc +1 more source
Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. [PDF]
Rosenberg D+11 more
europepmc +1 more source
[Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version)]. [PDF]
Zhou C+15 more
europepmc +1 more source
Summary of evidence to facilitate the implementation of advance care planning among advanced cancer patients. [PDF]
Tan M, Tang S, Huang C, Xiao J, Ding J.
europepmc +1 more source